WO1991018981A3 - Facteurs de croissance neurotropes comprenant un peptide homeoboite - Google Patents

Facteurs de croissance neurotropes comprenant un peptide homeoboite Download PDF

Info

Publication number
WO1991018981A3
WO1991018981A3 PCT/FR1991/000444 FR9100444W WO9118981A3 WO 1991018981 A3 WO1991018981 A3 WO 1991018981A3 FR 9100444 W FR9100444 W FR 9100444W WO 9118981 A3 WO9118981 A3 WO 9118981A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth factors
homeobox peptide
neurotropic growth
homeobox
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1991/000444
Other languages
English (en)
Other versions
WO1991018981A2 (fr
Inventor
Alain Joliot
Alain Prochiantz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to DE69122472T priority Critical patent/DE69122472T2/de
Priority to BR919105783A priority patent/BR9105783A/pt
Priority to EP91910774A priority patent/EP0485578B1/fr
Publication of WO1991018981A2 publication Critical patent/WO1991018981A2/fr
Publication of WO1991018981A3 publication Critical patent/WO1991018981A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Nouvelle classe de facteurs de croissance cellulaires, actifs en particulier sur les cellules nerveuses, lesdits facteurs comprenant au moins un peptide homéoboîte, éventuellement lié à une autre séquence peptidique.
PCT/FR1991/000444 1990-06-05 1991-06-05 Facteurs de croissance neurotropes comprenant un peptide homeoboite Ceased WO1991018981A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE69122472T DE69122472T2 (de) 1990-06-05 1991-06-05 Neurotropische wachstumsfaktoren, die ein homeobox-peptid enthalten
BR919105783A BR9105783A (pt) 1990-06-05 1991-06-05 Polipeptidio,processo para o tratamento em vidro de neuronios e composicoes celular e farmaceutica
EP91910774A EP0485578B1 (fr) 1990-06-05 1991-06-05 Facteurs de croissance neurotropes comprenant un peptide homeoboite

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006912A FR2662698A1 (fr) 1990-06-05 1990-06-05 Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite.
FR90/06912 1990-06-05

Publications (2)

Publication Number Publication Date
WO1991018981A2 WO1991018981A2 (fr) 1991-12-12
WO1991018981A3 true WO1991018981A3 (fr) 1992-03-19

Family

ID=9397246

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1991/000444 Ceased WO1991018981A2 (fr) 1990-06-05 1991-06-05 Facteurs de croissance neurotropes comprenant un peptide homeoboite

Country Status (9)

Country Link
EP (1) EP0485578B1 (fr)
JP (1) JP3282130B2 (fr)
AT (1) ATE143691T1 (fr)
BR (1) BR9105783A (fr)
DE (1) DE69122472T2 (fr)
FR (1) FR2662698A1 (fr)
IE (1) IE911914A1 (fr)
PT (1) PT97877A (fr)
WO (1) WO1991018981A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
FR2682875A1 (fr) * 1991-10-24 1993-04-30 Fidia France Sarl Utilisation de l'acide polysialique alpha2-8 pour la regulation de l'action des peptides homeoboites.
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
US5846743A (en) * 1995-02-22 1998-12-08 Brigham And Women's Hospital, Inc. Polyphoshoinositide binding peptides for intracellular drug delivery
GB9519275D0 (en) * 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
DE69736351T4 (de) 1996-05-08 2009-07-23 Cyclacel Ltd. Methoden und mittel zur hemmung der cdk4-aktivität
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
US6800286B1 (en) 1998-08-19 2004-10-05 The Regents Of The University Of Colorado Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
ATE419273T1 (de) 1998-11-13 2009-01-15 Cyclacel Ltd Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
FR2810046B1 (fr) * 2000-06-07 2004-09-10 Neurotech Procede d'immortalisation conditionnelle de cellules et les constructions proteiques pour sa mise en oeuvre
PL1799230T3 (pl) 2004-08-27 2013-05-31 Cyclacel Ltd Purynowe i pirymidynowe inhibitory CDK i ich zastosowanie do leczenia chorób autoimmunologicznych
FR2897780B1 (fr) 2006-02-28 2008-05-23 Centre Nat Rech Scient Utilisation de la proteine a homeodomaine engrailed comme anxiolytique
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CA2758378A1 (fr) 2009-04-14 2010-10-21 Trojan Technologies Ltd. Molecules therapeutiques antennapedia-anticorps et leurs procedes d'utilisation
GB201507722D0 (en) 2015-05-06 2015-06-17 Norwegian Univ Sci & Tech Ntnu Anti-bacterial agents and their use in therapy
EP3960195B1 (fr) * 2015-09-23 2025-01-08 Centre national de la recherche scientifique Engrailed pour le traitement de la sclérose latérale amyotrophique
AU2024207403A1 (en) 2023-01-13 2025-07-24 Brainever Stabilized engrailed protein aqueous compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006757A1 (fr) * 1988-12-15 1990-06-28 The Regents Of The University Of California Greffe de cellules genetiquement modifiees pour le traitement de maladies du systeme nerveux central

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006757A1 (fr) * 1988-12-15 1990-06-28 The Regents Of The University Of California Greffe de cellules genetiquement modifiees pour le traitement de maladies du systeme nerveux central

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Bio Essays, volume 10, nos. 2,3, février-mars 1989, D.G. Wilkinson: "Homeobox genes and development of the vertebrate CNS", pages 82-85, voir l'article en entier *
Cell, volume 55, 18 novembre 1988, Cell Press, M. Levine et al.: "Homeobox proteins as sequence-specific transcription factors", pages 537-540, voir l'article en entier *
Mol. Cell. Biol., volume 6, no. 12, décembre 1986, American Society for Microbiology, A. Laughon et al.: "Structure of transcripts from the homeotic antennapedia gene of drosophila melanogaster: Two promoters control the major protein-coding region", pages 4676-4689, voir l'article en entier, en particulier figure 8 *
Nature, volume 318, 19/26 décembre 1985, C. Desplan et al.: "The drosophila developmental gene, engrailed, encodes a sequence-specific DNA binding activity", pages 630-635, voir l'article en entier *
Nucleic Acids Research, volume 17, 1989, IRL Press, D. Acampora et al.: "The human HOX gene familiy", pages 10385-10402, voir l'article en entier (cité dans la demande) *
Proc. Natl. Acad. Sci. USA, volume 83, décembre 1986, Developmental Biology, A. Fainsod et al.: "The homeo domain of a murine protein binds 5' to its own homeo box", pages 9532-9536, voir l'article en entier *
Proc. Natl. Acad. Sci. USA, volume 88, no. 5, mars 1991, Neurobiology, A. Joliot et al.: "Antennapedia homeobox peptide regulates neural morphogenesis", pages 1864-1868, voir l'article en entier *
Proc. Natl. Acad. Sci., volume 86, juin 1989, Neurobiology, P. Ernfors et al.: "A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons", pages 4756-4760, voir l'article en entier (cité dans la demande) *
The EMBO Journal, volume 7, no. 13, 20 décembre 1988, IRL Press Limited (GB) G. Otting et al.: "Secondary structure determination for the antennapedia homeodomain by nuclear magnetic resonance and evidence for a helix-turn-helix motif", pages 4305-4309, voir l'article en entier (cité dans la demande) *
The EMBO Journal, volume 7, no. 13, 20 décembre 1988, M. M}lLer et al.: "Isolation and sequence-specific DNA binding of the antennapedia homeodomain", pages 4299-4304, voir l'article en entier (cité dans la demande) *
The EMBO Journal, volume 7, no. 7, 1988, IRL Press Ltd, (GB) K.W.Y. Cho et al.: "Differential utilization of the same reading frame in a xenopus homeobox gene encodes two related proteins sharing the same DNA-binding specificity", pages 2139-2149, voir l'article en entier, en particulier figure 5 et page 2144, colonne 1 *

Also Published As

Publication number Publication date
FR2662698A1 (fr) 1991-12-06
IE911914A1 (en) 1991-12-18
WO1991018981A2 (fr) 1991-12-12
DE69122472D1 (de) 1996-11-07
PT97877A (pt) 1992-04-30
FR2662698B1 (fr) 1995-03-24
JPH05502885A (ja) 1993-05-20
EP0485578B1 (fr) 1996-10-02
ATE143691T1 (de) 1996-10-15
BR9105783A (pt) 1992-07-21
DE69122472T2 (de) 1997-04-17
JP3282130B2 (ja) 2002-05-13
EP0485578A1 (fr) 1992-05-20

Similar Documents

Publication Publication Date Title
AU5483490A (en) Bilevel contact solar cells
AU5605094A (en) Heterojunction solar cell
AU588197B2 (en) Electrochemical cell
CA2267651A1 (fr) Methode pour stimuler la croissance de cellules precurseurs melanocytes avec des cellules facteurs souches polypeptides
AU3969689A (en) Bio-reactor cell culture process
AU6226890A (en) Solid electrolyte fuel cell
AU3228789A (en) Biologically active proteins
IE881755L (en) Novel proteins with factor viii activity, process for their¹preparation using genetically engineered cells and¹pharmaceutical compositions containing them
AU9087891A (en) Electrochemical cell
AU1452288A (en) Solar cell
AU3560093A (en) Cell extension in a cellular telephone system
FR2662698B1 (fr)
AU7377587A (en) Electrochemical cell
AU7454894A (en) Use of stable form of limno2 as cathode in lithium cell
AU3773795A (en) Electrochemical cell
USD263393S (en) Solar cell
AU9092391A (en) Efficiency enhancement for solid-electrolyte fuel cell
AU679038B2 (en) Electrode arrangement for gas-forming electrolytic processes in membrane cells and its use
AU2474088A (en) Cell growth inhibitory factor
EP0478185A3 (en) Fuel electrodes for solid oxide fuel cells and production thereof
AU673414B2 (en) Cathodic active material composition for dry cells, method for preparing the same, and alkaline battery
AU610900B2 (en) Immunosuppressant peptides
AU2334888A (en) Thymic stroma-derived t cell growth factor and the production
AU595598B2 (en) High potency sweetening agents
GB2284599A8 (en) Solid-electrolyte fuel cell electrode material andelectrode using same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991910774

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): BR JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWP Wipo information: published in national office

Ref document number: 1991910774

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991910774

Country of ref document: EP